Rahul Sahgal – CEO, Swiss-American Chamber of Commerce
Rahul Sahgal brings over 20 years of experience in both the private sector and government to his role as CEO of the Swiss-American Chamber of Commerce, uniquely positioning him to…
The Swiss-American Chamber of Commerce plays a vital and active role in assisting Swiss companies in the United States and U.S. companies in Switzerland to expand their business. The Swiss-American Chamber of Commerce is a not-for-profit organization.
Relations between Switzerland and the United States of America are extremely diverse and enjoy a rich tradition. The United States is the second largest export market for Switzerland and an important hub for education and research. Over the last 12 years, exports to America have doubled in volume, going from 10.6 to 14.5 percent of all Swiss exports between 2004 and today. Swiss pharmaceutical exports account for approximately 47 percent of trade with America.
Contact
Talacker 41, 8001 Zurich, Switzerland, Phone: +41 43 443 72 00
Rahul Sahgal brings over 20 years of experience in both the private sector and government to his role as CEO of the Swiss-American Chamber of Commerce, uniquely positioning him to…
In a wide-ranging conversation, Martin Naville of AmCham Switzerland looks at the evolution of the Switzerland-US trade relationship and the importance of pharma within it, the pressing need for a…
Martin Naville, CEO of the Swiss-American Chamber of Commerce, discusses Swiss exports to the US, global competitiveness and innovation rankings, and why the Swiss-US relationship will only continue to grow…
“Get it done! That is what CARBOGEN AMCIS is all about!” – The CEO of the Swiss drug development and commercialization services company elaborates on the company’s strong mindset and…
The most innovative country in the world must constantly launch new initiatives to attract R&D activities if that lead is to be maintained, and Switzerland Innovation is doing just that…
The Executive Director of the Greater Geneva Bern area, Western Switzerland’s investment promotion agency, elaborates on the unique assets the region has to offer, and highlights the strong pro-business mindset…
Backed by the Japanese Zeria Group, fast growing gastrointestinal (GI) specialist Tillotts Pharma is looking to acquire further GI assets after its recent USD 200m M&A deal. The company is…
Switzerland has been long-established as one of the world’s most innovative countries and boasts a thriving ecosystem of startup biotechs. However, a slow and complex funding cycle means that an…
Recognized as one of the ten most innovative companies in the world, Hamilton has a regional HQ, strategic R&D and manufacturing operations tucked high away in the scenic Swiss Alps.…
The president of BD Europe analyses current trends and challenges in European healthcare and highlights how BD is positioning itself as a solutions provider and partner to cope with this new…
The global leader in the specialized niche of micronization services, Jetpharma is set for continued steady growth driven by the continued development of extremely dangerous-to-handle highly potent active ingredients. To…
Patient-driven drug pricing, the uncertain future of Switzerland’s tax regime, and new business models for life science innovators in a changing global market are just a few of the topics…
Well-funded and with a stellar pipeline, TESARO is an up and coming Boston-based oncology biotech ready to launch their two first products in the European market in 2017. Orlando, we…
Recently arrived from Germany, ALK’s new general manager for Switzerland highlights some of the unique features of the Swiss allergology field, and some of the opportunities for ALK to positively…
With 35 years’ experience in natural extracts, purified ingredients, semi-synthetic APIs of natural origin and manufacturing products to the highest standards of excellence and quality, Linnea is a ground-breaking company…
See our Cookie Privacy Policy Here
